Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced solid tumors, inclu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenocarcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Papillary Thyroid Cancer

Drugs mentioned

• CM24
• nivolumab (nivolumab)

Snippet

Sponsor: Famewave Ltd. | Conditions: Solid Tumor, Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED